ICP
AGN

Ironvine Capital Partners’s Allergan plc AGN Stock Holding History

Ironvine Capital Partners’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-30,790
Closed -$5.87M – 62
2018
Q3 		$5.87M Sell
30,790
-24,016
-44% -$4.41M 1.2% 29
2018
Q2 		$9.14M Sell
54,806
-386
-0.7% -$62K 2.04% 23
2018
Q1 		$9.29M Buy
55,192
+14,877
+37% +$2.5M 2.24% 17
2017
Q4 		$6.59M Buy
+40,315
New +$7.23M 2.06% 21

Other funds holding AGN

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Edgewood Management
Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return
LP
Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return

Ironvine Capital Partners's AGN Position: Q4 2018 in Review

Ironvine Capital Partners sold out of Allergan plc (AGN) in Q4 2018, closing a stake of 30,790 shares — an estimated $5.87M sold.

Ironvine Capital Partners first reported a position in AGN in Q4 2017 and held it in 4 quarters. The position peaked at $9.29M in Q1 2018. 1,007 funds tracked by Wall St. Rank hold AGN as of Q4 2018.

  • Ironvine Capital Partners reported no remaining Allergan plc position as of Q4 2018 after selling out during the quarter.
  • Ironvine Capital Partners sold 30,790 Allergan plc shares in Q4 2018, an estimated $5.87M.
  • Ironvine Capital Partners first reported a position in Allergan plc in Q4 2017 and held it in 4 quarters.
  • Ironvine Capital Partners's Allergan plc position peaked at $9.29M in Q1 2018.
  • 1,007 funds tracked by Wall St. Rank held Allergan plc as of Q4 2018.

Based on Ironvine Capital Partners's 13F filing for Q4 2018, filed 30 Jan 2019.